Elisabetta Mereu

Dr. Elisabetta Mereu


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 February 2021 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
MEMarc Elosua-Bayes
Marc Elosua-Bayes
PNPaula Nieto
Paula Nieto
EMElisabetta Mereu
Elisabetta Mereu
IGIvo Gut
Ivo Gut
HHHolger Heyn
Holger Heyn
Spatially resolved gene expression profiles are key to understand tissue organization and function. However, spatial transcriptomics (ST) profiling techniques lack single-cell resolution and require a combination with single-cell RNA sequencing (scRNA-seq) information to deconvolute the spatially indexed datasets. Leveraging the strengths of both data types, we developed SPOTlight, a computational tool that enables the integration of ST with scRNA-seq data to infer the location of cell types and states within a complex tissue. SPOTlight is centered around a seeded non-negative matrix factorization (NMF) regression, initialized using cell-type marker genes and non-negative least squares (NNLS) to subsequently deconvolute ST capture locations (spots). Simulating varying reference quantities and qualities, we confirmed high prediction accuracy also with shallowly sequenced or small-sized scRNA-seq reference datasets. SPOTlight deconvolution of the mouse brain correctly mapped subtle neuronal cell states of the cortical layers and the defined architecture of the hippocampus. In human pancreatic cancer, we successfully segmented patient sections and further fine-mapped normal and neoplastic cell states. Trained on an external single-cell pancreatic tumor references, we further charted the localization of clinical-relevant and tumor-specific immune cell states, an illustrative example of its flexible application spectrum and future potential in digital pathology.

6 April 2020 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
EMElisabetta Mereu
Elisabetta Mereu
ALAtefeh Lafzi
Atefeh Lafzi
CMCatia Moutinho
Catia Moutinho
CZChristoph Ziegenhain
Christoph Ziegenhain
DMDavis J. McCarthy
Davis J. McCarthy
HHHolger Heyn
Holger Heyn

26 July 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
AGAlba Garrido-Trigo
Alba Garrido-Trigo
ACAna M. Corraliza
Ana M. Corraliza
MVMarisol Veny
Marisol Veny
IDIsabella Dotti
Isabella Dotti
EMElisa Melón-Ardanaz
Elisa Melón-Ardanaz
ASAZUCENA SALAS
AZUCENA SALAS
Ulcerative colitis and Crohn’s disease are chronic inflammatory intestinal diseases with perplexing heterogeneity in disease manifestation and response to treatment. While the molecular basis for this heterogeneity remains uncharacterized, single-cell technologies allow us to explore the transcriptional states within tissues at an unprecedented resolution which could further understanding of these complex diseases. Here, we apply single-cell RNA-sequencing to human inflamed intestine and show that the largest differences among patients are present within the myeloid compartment including macrophages and neutrophils. Using spatial transcriptomics in human tissue at single-cell resolution (CosMx Spatial Molecular Imaging) we spatially localize each of the macrophage and neutrophil subsets identified by single-cell RNA-sequencing and unravel further macrophage diversity based on their tissue localization. Finally, single-cell RNA-sequencing combined with single-cell spatial analysis reveals a strong communication network involving macrophages and inflammatory fibroblasts. Our data sheds light on the cellular complexity of these diseases and points towards the myeloid and stromal compartments as important cellular subsets for understanding patient-to-patient heterogeneity.

12 February 2020 in Genome Biology
Verified
Journal Article
Open access
PDF file
CHChristian Holland
Christian Holland
JTJovan Tanevski
Jovan Tanevski
JPJavier Perales-Patón
Javier Perales-Patón
JGJan Gleixner
Jan Gleixner
MKManu P. Kumar
Manu P. Kumar
JSJulio Saez-Rodriguez
Julio Saez-Rodriguez
Background: Many functional analysis tools have been developed to extract functional and mechanistic insight from bulk transcriptome data. With the advent of single-cell RNA sequencing (scRNA-seq), it is in principle possible to do such an analysis for single cells. However, scRNA-seq data has characteristics such as drop-out events and low library sizes. It is thus not clear if functional TF and pathway analysis tools established for bulk sequencing can be applied to scRNA-seq in a meaningful way.Results: To address this question, we perform benchmark studies on simulated and real scRNA-seq data. We include the bulk-RNA tools PROGENy, GO enrichment, and DoRothEA that estimate pathway and transcription factor (TF) activities, respectively, and compare them against the tools SCENIC/AUCell and metaVIPER, designed for scRNA-seq. For the in silico study, we simulate single cells from TF/pathway perturbation bulk RNA-seq experiments. We complement the simulated data with real scRNA-seq data upon CRISPR-mediated knock-out. Our benchmarks on simulated and real data reveal comparable performance to the original bulk data. Additionally, we show that the TF and pathway activities preserve cell type-specific variability by analyzing a mixture sample sequenced with 13 scRNA-seq protocols. We also provide the benchmark data for further use by the community.Conclusions: Our analyses suggest that bulk-based functional analysis tools that use manually curated footprint gene sets can be applied to scRNA-seq data, partially outperforming dedicated single-cell tools. Furthermore, we find that the performance of functional analysis tools is more sensitive to the gene sets than to the statistic used.

1 March 2017 in Genome Biology
Verified
Journal Article
Open access
PDF file
AGAmy Guillaumet-Adkins
Amy Guillaumet-Adkins
GRGustavo Rodriguez-Esteban
Gustavo Rodriguez-Esteban
EMElisabetta Mereu
Elisabetta Mereu
MMMaria Mendez-Lago
Maria Mendez-Lago
DJDiego A. Jaitin
Diego A. Jaitin
HHHolger Heyn
Holger Heyn
A variety of single-cell RNA preparation procedures have been described. So far, protocols require fresh material, which hinders complex study designs. We describe a sample preservation method that maintains transcripts in viable single cells, allowing one to disconnect time and place of sampling from subsequent processing steps. We sequence single-cell transcriptomes from >1000 fresh and cryopreserved cells using 3'-end and full-length RNA preparation methods. Our results confirm that the conservation process did not alter transcriptional profiles. This substantially broadens the scope of applications in single-cell transcriptomics and could lead to a paradigm shift in future study designs.

16 January 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
RMRicardo Martins-Ferreira
Ricardo Martins-Ferreira
JCJosep Calafell-Segura
Josep Calafell-Segura
BLBárbara Leal
Bárbara Leal
JRJavier Rodríguez-Ubreva
Javier Rodríguez-Ubreva
EMElena Martínez-Saez
Elena Martínez-Saez
EBEsteban Ballestar
Esteban Ballestar
Dysregulated microglia activation, leading to neuroinflammation, is crucial in neurodegenerative disease development and progression. We constructed an atlas of human brain immune cells by integrating nineteen single-nucleus RNA-seq and single-cell RNA-seq datasets from multiple neurodegenerative conditions, comprising 241 samples from patients with Alzheimer’s disease, autism spectrum disorder, epilepsy, multiple sclerosis, Lewy body diseases, COVID-19, and healthy controls. The integrated Human Microglia Atlas (HuMicA) included 90,716 nuclei/cells and revealed nine populations distributed across all conditions. We identified four subtypes of disease-associated microglia and disease-inflammatory macrophages, recently described in mice, and shown here to be prevalent in human tissue. The high versatility of microglia is evident through changes in subset distribution across various pathologies, suggesting their contribution in shaping pathological phenotypes. A GPNMB-high subpopulation was expanded in AD and MS. In situ hybridization corroborated this increase in AD, opening the question on the relevance of this population in other pathologies.